Kinin B1 receptors as a therapeutic target for inflammation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Kinin B1 receptors as a therapeutic target for inflammation

Published:2017-11-30 Issue:1 Volume:22 Page:31-44
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Qadri Fatimunnisa¹,Bader Michael¹²³⁴⁵^ORCID

Affiliation:

1. Max-Delbrück Center for Molecular Medicine (MDC), Berlin, Germany

2. Berlin Institute of Health (BIH), Berlin, Germany

3. Charité University Medicine Berlin, Germany

4. German Center for Cardiovascular Research (DZHK) site Berlin, Berlin, Germany

5. Institute for Biology, University of Lübeck, Lübeck, Germany

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2018.1409724

Reference226 articles.

1. New insights into the resolution of inflammation

2. Cellular carboxypeptidases

3. The Kallikrein-Kinin System: Current and Future Pharmacological Targets

4. Molecular biology of the kallikrein-kinin system: from structure to function

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinin B1 receptor and TLR4 interaction in inflammatory response;Inflammation Research;2024-07-04

2. Recent advances in the discovery and development of drugs targeting the kallikrein-kinin system;Journal of Translational Medicine;2024-04-26

3. Evidence from fatal COVID-19 for targeting the bradykinin metabolism - a single-center cohort study;Shock;2023-10-13

4. The effect of bradykinin 1 receptor antagonist BI 1026706 on pulmonary inflammation after segmental lipopolysaccharide challenge in healthy smokers;Pulmonary Pharmacology & Therapeutics;2023-10

5. Bradykinin-Mediated Angioedema Induced by Commonly Used Cardiovascular Drugs;Drugs and Drug Candidates;2023-09-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3